Genesco Inc. (GCO) Stock Price & Analysis
Genesco Inc. (GCO) closed at USD 37.39 on Thursday, October 22, 2026, up 3.20% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 36.23; the Oct 22, 2026 session ranged USD 36.14–37.5 on volume of 115,386 shares. Market capitalization is $404.57M, with a 52-week range of USD 21.93–43.6 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GCO.md
Key facts (GCO)
- Last four reported quarters (through Aug 1, 2026): revenue $2.43B, net income $41.6M (1.7% margin), free cash flow $73.8M (SEC filings).
- Valuation: P/E 9.7x (avg 23.2x at the last 1 fiscal year-ends), EV/EBITDA 3.6x, net cash $41.3M.
- 1 of 80 tracked superinvestors hold GCO (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market purchases, last ~7 months: 2 Form 4 filings, $110K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.75 on a 1–5 scale) (4 analysts), mean target USD 39.67 (range 36–45).
- Total return with dividends: 1Y +23.9% vs S&P 500 +14.9%; 5Y -38.0% vs S&P 500 +80.3%.
- Next earnings: 2026-12-03, EPS estimate USD 0.93, revenue estimate $591M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (GCO)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.42B | $2.38B | $2.32B | $2.33B | $2.44B | $2.43B |
| Gross profit | $1.18B | $1.14B | $1.10B | $1.10B | $1.13B | — |
| Operating income | $156M | $93.2M | -$13.5M | $13.9M | $17.3M | $48.1M |
| Net income | $115M | $71.9M | -$16.8M | -$18.9M | $13.3M | $41.6M |
| EPS (diluted) | $7.92 | $5.66 | -$1.50 | -$1.74 | $1.25 | — |
| Free cash flow | $186M | -$225M | $34.5M | $46.8M | $83.7M | $73.8M |
| Gross margin | 48.8% | 47.6% | 47.3% | 47.2% | 46.3% | — |
| Operating margin | 6.4% | 3.9% | -0.6% | 0.6% | 0.7% | 2.0% |
| Net margin | 4.7% | 3.0% | -0.7% | -0.8% | 0.5% | 1.7% |
| Revenue growth | +35.6% | -1.5% | -2.5% | +0.0% | +4.8% | — |
| Cash + short-term investments | $321M | $48.0M | $35.2M | $34.0M | $105M | — |
| Total debt | $15.7M | $44.9M | $34.7M | $0K | $3.4M | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 1, 2026) (GCO)
P/E 9.7x · P/S 0.2x · EV/EBITDA 3.6x · EV/Sales 0.1x · P/FCF 5.5x · P/B 0.7x · FCF yield 18.25% · Earnings yield 10.29% · Buyback yield (TTM) 0.00% · Net cash $41.3M · EV $363M
P/E at fiscal year-ends: Jan 2026 23.2x.
Superinvestors (SEC 13F-HR, Q2 2026) (GCO)
1 of 80 tracked investors hold GCO. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management | 0.11% | $37.1M | Added +1.7% |
Insider purchases (SEC Form 4, open-market, last ~7 months) (GCO)
2 purchases, $110K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-21 | Collins Jonathan M. | SVP Finance and CFO | 295 | $10K | 33.84 | Too little history (no open-market trades in 2023–2025) |
| 2026-07-09 | Sandfort Gregory A | Director | 2,958 | $100K | 33.8 | Too little history (no open-market trades in 2024) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (GCO)
Consensus Hold (mean 2.75 on a 1–5 scale), 4 analysts; mean target USD 39.67 (low 36, high 45).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-04 | Truist Securities | Target lowered | Hold | $40 → $38 |
Total return (dividends reinvested) (GCO)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +23.9% | -38.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +24.0% | -9.1% |
| Volatility (annualized) | 63.1% | 64.5% |
| Max drawdown | -38.8% (Nov 2025→Dec 2025) | -74.7% (Mar 2022→Mar 2025) |
GCO analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $0.93 | $1.19 | -22.2% | $591.2M | 4 |
| Next quarter (ends Jan 2027) | $4.24 | $4.40 | -3.7% | $775.3M | 4 |
| Current fiscal year (ends Jan 2027) | $2.36 | $2.25 | +5.0% | $2.38B | 4 |
| Next fiscal year (ends Jan 2028) | $2.95 | $2.86 | +3.1% | $2.44B | 4 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 37.39 |
|---|---|
| Change | ▲ 3.20% (up) |
| Previous Close | USD 36.23 |
| Open | USD 35.88 |
| Day Range | USD 36.14 – 37.5 |
| 52-Week Range | USD 21.93 – 43.6 |
| Volume | 115,386 shares |
| Market Cap | $404.57M |
| Exchange | NYQ |
Technical Analysis (GCO)
Nexqual's technical model rates GCO "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.42 (neutral) |
| vs SMA50 | Above (USD 34.92) |
| MACD | 0.58 (positive) |
Analyst Ratings (GCO)
Wall Street analysts rate GCO "Hold" based on 4 analysts, with a mean price target of USD 39.67 (range USD 36–45), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 39.67 |
| High Target | USD 45 |
| Low Target | USD 36 |
| Buy / Hold / Sell | 1 / 3 / 0 |
Earnings (GCO)
| Next Earnings Date | 2026-12-03 |
|---|---|
| EPS Estimate | USD 0.93 |
| Revenue Estimate | $591.24M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD -0.83 vs est -1.38 ▲ beat |
| 2026-04-30 | USD -2.18 vs est -2.57 ▲ beat |
| 2026-01-31 | USD 3.74 vs est 3.59 ▲ beat |
| 2025-10-31 | USD 0.79 vs est 0.86 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (GCO)
| Total Revenue | $2.43B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -3.00% |
| Gross Margin | +46.65% |
| Operating Margin | -3.10% |
| Profit Margin | +1.71% |
| ROE | +7.83% |
| Debt / Equity | 1.05 |
| Current Ratio | 1.59 |
| Total Cash | $57.13M |
| Total Debt | $583.91M |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $73.84M (3.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (GCO)
Nexqual rates Genesco Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Mixed — Revenue +4.8% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 47%, operating -3% (last 12 months) |
| Balance Sheet | Mixed — $57M cash and investments vs $16M debt (Aug 2026, SEC), net cash |
| Cash Flow | Mixed — FCF $74M (last 4 quarters to Aug 2026, SEC), slim 3.0% margin |
| Efficiency | Mixed — ROE 8%, ROA 1.1% |
Ownership (GCO)
| Insider Ownership | +14.07% |
|---|---|
| Institutional Ownership | +96.19% |
| Shares Outstanding | 10.82M |
| Float | 8.64M |
| Short % of Float | +12.85% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (GCO)
Genesco Inc. is led by Mimi Eckel Vaughn, President, CEO & Chairman, per Nexqual as of October 23, 2026 at 09:26 UTC.
| President, CEO & Chairman | Mimi Eckel Vaughn |
|---|---|
| Senior VP of Finance & CFO | Jonathan M. Collins |
| Senior Director of FP & A & Investor Relations | Darryl MacQuarrie |
| Senior VP and President of Johnston & Murphy Group | Daniel E. Ewoldsen |
| President of Schuh | Tomas Petersson |
Major Backers & Investors (GCO)
Notable institutional backers of Genesco Inc. include Pzena Investment Management LLC, Fund 1 Investments, LLC, Acadian Asset Management. LLC, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Pzena Investment Management LLC | 10.15% |
| Fund 1 Investments, LLC | 5.64% |
| Acadian Asset Management. LLC | 4.19% |
| Healthcare of Ontario Pension Plan Trust Fund | 2.77% |
| Charles Schwab Investment Management, Inc. | 2.77% |
| Jacobs Levy Equity Management, Inc. | 2.61% |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.48% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.41% |
| Dimensional Fund Advisors | 6.09% |
| Vanguard Group | 3.74% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTRN | Citi Trends, Inc. | USD 46 | ▲ 0.17% |
| SHOE | Shoe Station Group, Inc. | USD 14.22 | ▲ 7.56% |
| SFIX | Stitch Fix, Inc. | USD 2.72 | ▲ 5.63% |
| CAL | Caleres, Inc. | USD 13.35 | ▲ 4.95% |
| JILL | J. Jill, Inc. | USD 22.85 | ▼ 2.02% |
| REF | Reformation Inc. | USD 15.03 | ▲ 7.43% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt